Pioglitazone-induced acute severe hepatitis;Hépatite aiguë sévère à la pioglitazone

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 6-7 I, 2004, Pages 610-611

  Arotçarena, Ramuntxo ^a   Bigué, Jean Paul ^a   Etcharry, Francine ^b   Pariente, Alex ^a  

^a CENTRE HOSPITALIER DE PAU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; DEXTROPROPOXYPHENE; DILTIAZEM; DOXAZOSIN; GLIBENCLAMIDE; LISINOPRIL; MAGNESIUM; METFORMIN; METOLAZONE; MULTIVITAMIN; OMEPRAZOLE; PARACETAMOL; PIOGLITAZONE; SIMVASTATIN; VENLAFAXINE; VERAPAMIL; VITAMIN D; VOGLIBOSE;

ACUTE HEPATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEVER; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; TREATMENT OUTCOME;

EID: 3142715769     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)95021-x     Document Type: Article

References (10)

1. Scheen AJ. Atteintes hépatitques médicamenteuses Qu'apportent les échelles diagnostiques. Diabetes Metab 2001;27:305-13.
2. Danan G. Drug induced acute hepatic injury. What is the value of diagnostic scale? Gastroenterol Clin Biol 2003;27:B21-5.
3. May LD, Lefkowitch JH, Kram MT. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Ann Intern Med 2002;136:449-52.
4. Maeda K. Hepatocellular injury in a patient receiving pioglitazone. Ann Intern Med 2001;135:306.
5. Pinto AG, Cummings OW, Chalasani N. Severe but reversible cholestatic liver injury after pioglitazone therapy. Ann Intern Med 2002;137: 857.
6. Nagasaka S, Abe A, Kawakami A, Kusaka T, Ishikawa S, Saito T, et al. Pioglitazone induced hepatic injury in a patient previously receiving troglitazone with success. Diabetic Medicine 2002;19:344-8.
7. Chase MP, Yarze JC. Pioglitazone-associated fulminant hepatic failure. Am J Gastroenterol 2002;97:502-3.
8. Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone. Dig Dis Sci 2002 47:1632-7.
9. Belcher G, Matthews DR. Safety and tolerability of pioglitazone. Exp Clin Endocrinol Diabetes 2000;108:S267-73.
10. Graham DJ, Green L, Senior JR. Hyperacute liver failure induced by troglitazone: what did we learn and what do we need to learn (abstract). Hepatology 2002;36:168A.